Page 175 - MALAYSIA HEALTH SECTOR RESPONSE TO COVID-19 PANDEMIC: PERSPECTIVES FROM THE FIELD
P. 175

Besides, IMR is also conducting a similar ongoing study  to develop a simple
                                                                          39
                    close-tube RT-LAMP assay for COVID-19 that can be carried out by personnel
                    with minimal training and without needing any sophisticated equipment.
                    Therefore, an in-house diagnostic assay developed with minimal machine-
                    dependence should be preferable for detecting  SARS-CoV-2 in  the  local
                    setting.

                                                                                          40
                    Unfalteringly exploring other alternatives,  IMR  conducted  a  study   to
                    evaluate the performance of the COVID-19 in vitro diagnostic test kits for
                    the detection of  the  COVID-19 antigen RNA by reverse transcriptase
                    polymerase chain reaction and antibody. Of the 43 RT-PCR test kits received
                    for evaluation, 69.7% (30 kits) met the acceptance criteria. Meanwhile, for
                    antibody and antigen kits, the percentage of test kits  that  reached the
                    acceptance criteria for local marketing was 34% (15/44) and 33.3% (4/12),
                    respectively. The final decision on the test kit's approval would be decided
                    by  the  Medical Device Authority (MDA)  expert committee,  based on the
                    performance report published by the IMR laboratory.



                    Exploring alternative specimens for the detection of SARS-CoV-2

                    The comparability of patient-performed testing  using  a morning saliva
                    sample with the current standard testing method of sampling via a
                                                                                         41
                    nasopharyngeal swab (NPS) done by a HCW was also explored by IMR . The
                    findings demonstrated that saliva was a better alternative specimen for the
                    detection of SARS-CoV-2. Considering the simplicity of specimen collection,
                    shortage of PPE, and the virus's transmissibility, saliva sampling could assist
                    in the sampling protocol, management of patients, and reduce the hazard
                    exposure among  HCWs.  Furthermore,  the detection rate of SARS-CoV-2
                    between healthcare worker-collected nasopharyngeal and oropharyngeal
                    (NP+OP) swabs  compared to that of  patient-performed self-collected
                    random saliva was also assessed in another  IMR  study . The  findings
                                                                               42
                    demonstrated  that random saliva  was  a better alternative diagnostic
                    specimen for detecting SARS-CoV-2; however, it might be subject to several
                    limitations as well.








 EVIDENCE-BASED RESPONSES TO THE THIRD COVID-19 WAVE IN MALAYSIA     EVIDENCE-BASED RESPONSES TO THE THIRD COVID-19 WAVE IN MALAYSIA  139

                                                        172
   170   171   172   173   174   175   176   177   178   179   180